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Granulomas play a key role in host protection against
mycobacterial pathogens, with their breakdown con-
tributing to exacerbated disease. To better under-
stand the initiation and maintenance of these struc-
tures, we employed both high-resolution multiplex
static imaging and intravital multiphoton microscopy
of Mycobacterium bovis BCG-induced liver granulo-
mas. We found that Kupffer cells directly capture
blood-borne bacteria and subsequently nucleate for-
mation of a nascent granuloma by recruiting both
uninfected liver-resident macrophages and blood-
derived monocytes. Within the mature granuloma,
these myeloid cell populations formed a relatively
immobile cellular matrix that interacted with a highly
dynamic effector T cell population. The efficient re-
cruitment of these T cells was highly dependent on
TNF-a-derived signals, which also maintained the
granuloma structure through preferential effects on
uninfectedmacrophage populations. By characteriz-
ing themigration of both innate and adaptive immune
cells throughout the process of granuloma develop-
ment, these studies provide a new perspective on
the cellular events involved inmycobacterial contain-
ment and escape.
INTRODUCTION
A protective immune response against pathogenic mycobacte-
rial infections depends on the de novo formation of organized
inflammatory lesions termed granulomas. Themicroenvironment
that develops within the granuloma fosters interactions between
innate and adaptive immune system components critical for
mycobacterial containment and maintenance of an asymptom-
atic state. The static spatial localization of cells within mycobac-
teria-induced granulomas has been extensively studied by stan-
dard histologic and immunohistochemical methods, leading to
speculation about the role(s) played by intragranuloma cell distri-
bution and interactions in effective host defense (Saunders andBritton, 2007; Ulrichs and Kaufmann, 2006). However, existing
studies have not provided information on cellular dynamics
within granulomas on the scale of minutes to hours, preventing
an appreciation of how active cell immigration, emigration, and
intralesional migration might contribute to the development
and maintenance of these protective structures. Likewise, infor-
mation is lacking on the connection between the earliest events
in bacterial uptake, the processes that underlie nascent granu-
loma formation and maturation, and the loss of host protection
that is seen in some individuals.
Infection of micewithMycobacterium bovisBacillus Calmette-
Gue´rin (BCG) represents a well-established model of cellular
immunity and granuloma formation (Kaufmann et al., 1995).
Intravenous (i.v.) infections with BCG result in a granulomatous
response in the liver, with the first of these structures being
clearly delineated at the histological level approximately 2 weeks
post-infection (p.i.) (Khalil et al., 1975). Critical to the generation
and maintenance of a protective mycobacterial granuloma is the
crosstalk between antigen-specific CD4+ ab T cells and infected
macrophages, producing an effector response in the latter cell
type that can prevent replication and/or mediate killing of intra-
cellular bacteria (Ladel et al., 1995a, 1995b). Tumor necrosis fac-
tor-a (TNF-a) is a primary mediator of granuloma development,
with the granulomatous response being severely impaired in
mice deficient in this gene product or its receptor (Algood
et al., 2003; Lin et al., 2007). Importantly, blockade of TNF-
a signaling in animals with established BCG granulomas results
in a loss in granuloma cellularity and protective function (Kindler
et al., 1989), demonstrating the critical role played by TNF-
a-derived signals in the maintenance of these structures. The
central role of TNF-a seen in experimental granuloma models
can explain recent observations of M. tuberculosis reactivation
in some patients treated with antagonists of the TNF-a pathway
(Wallis et al., 2004), providing a strong clinical rationale for further
studies of the interplay between this cytokine and the cells
involved in granuloma-dependent antimicrobial activity.
The ability to observe directly the behavior of individual cell
types during immune responses via in situ and intravital imaging
techniques has revealed the highly dynamic migratory behavior
of many hematopoietic cells, uncovered fundamental mecha-
nisms regulating cellular recruitment to inflamed tissues, and
permitted description of the cell-cell interactions involved in
the generation of effector responses and immunological memory
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examined the process of cellular recruitment to inflammatory
sites through blood vessels, recent experiments have focused
on the behavior of immune cells extravasating out of the vascu-
lature and entering the tissue parenchyma (Mempel et al., 2004).
However, the majority of these latter studies have focused on
lymphoid tissues, with only a handful examining inflammatory re-
sponses in nonlymphoid organs (Auffray et al., 2007; Boissonnas
et al., 2007; Geissmann et al., 2005; Kawakami et al., 2005;
Mrass et al., 2006) and still fewer looking at immune responses
to pathogens (Davis et al., 2002; Frevert et al., 2005). Thus, the
behavior of tissue-resident immune cells or those recruited
from the blood during an inflammatory response to an infectious
agent remains largely unexplored. Because the liver is amenable
to intravital microscopy (IVM) (Frevert et al., 2005; Geissmann
et al., 2005; McCuskey et al., 1983), the BCG infection model
represents an ideal system to examine host-pathogen interac-
tions and cellular dynamics throughout the process of mycobac-
terial granuloma formation.
Here we describe experiments utilizing a combination of high-
resolution, multiplexed static immunofluorescence microscopy
and dynamic multiphoton intravital imaging techniques to exam-
ine the initiation, development, and dissolution of mycobacterial
granulomas. We found that BCG was rapidly cleared from the
blood through direct capture and phagocytosis by liver-resident
macrophages (Kupffer cells [KCs]). These infected phagocytes
persisted within the liver for at least several weeks after infection,
nucleating the formation of granulomas through the attraction of
uninfected KCs and blood monocytes, both of which were de-
pendent on TNF-a-derived signals for their maintenance within
the structure. In contrast to the slowmovement of these myeloid
populations, which occurred over days to weeks, activated
CD4+ T cells readily entered but did not leave the granuloma,
within which they migrated rapidly in close apposition to the rel-
atively static myeloid cell network. Together, our observations
indicate that maintenance of a functional protective granuloma
environment involves the TNF-a-dependent maintenance of
a quasistatic myeloid cell scaffold in intimate contact with
a highly dynamic effector T cell population.
RESULTS
Direct Uptake and Clearance of Blood-Borne
Mycobacteria by Kupffer Cells
We first sought to identify the cellular components involved in the
initial interactions with BCG immediately after infection. Consis-
tent with the role of the liver as a primary site for clearance of sys-
temic infections (Benacerraf et al., 1959), mycobacteria were
rapidly depleted from the blood and became associated with
perfused liver tissue within 5 min of i.v. infection (see Figure S1
available online). Liver-mediated clearance of blood-borne path-
ogens is typically dependent on KCs attached to the luminal
walls of liver sinusoids, but may also involve other cell types
such as granulocytes (Gregory and Wing, 2002; Knolle and
Gerken, 2000). To investigate this issue, we utilized hepatic
two-photon IVM to observe directly the initial interactions be-
tween host cellular components and blood-borne BCG. Imaging
was performed on the surgically exposed livers of animals
acutely infected through an i.v. catheter with genetically modi-
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RFP). Visualization of innate immune cell components was
accomplished with either of two enhanced green fluorescent
protein (EGFP)-expressing mouse lines. Gene-targeted mice ex-
pressing EGFP under the control of the endogenous lysozymeM
promoter (LysM-EGFP) have fluorescent populations primarily
consisting of neutrophils, macrophages, and monocytes (Faust
et al., 2000), whereas animals bearing EGFP recombined into
the MHC class II I-Ab locus (MHCII-EGFP) contain fluorescent
macrophages, dendritic cells (DCs), and B cells (Boes et al.,
2002). As expected, in both lines KCs expressed EGFP and rep-
resented the primary fluorescent cell population within the liver
sinusoids as analyzed by IVM (Figure 1) or conventional tissue
immunohistology (Figure S2). Within 1 min of i.v. infection,
BCG became associated with the fluorescent KC population
(Figures 1A and 1B; Movies S1 and S2). Although neutrophils
(identified by their high EGFP expression) were occasionally
seen passively flowing through the sinusoidal spaces in the
LysM-EGFP mice, they did not appear to make direct contact
with the mycobacteria nor did they frequently take up this organ-
ism (Movie S2). Indeed, BCG appeared in intracellular compart-
ments at 15 min p.i., suggesting direct phagocytosis from the
bloodstream (Figure 1C; Movie S3). Even at 3 hr p.i., when nu-
merous neutrophils were migrating along the sinusoidal walls
in response to mycobacteria-induced inflammatory signals, we
were unable to observe any direct interactions between BCG
and neutrophils (Movie S4), suggesting that these cells do not
play a critical role in bacterial clearance by the liver during the
initial stages of infection.
Kupffer Cells Persist after BCG Infection
and Redistribute into Granulomas
Having demonstrated that KCs are responsible for direct uptake
ofmycobacteria from the blood, we then examined the fate of the
KC population during granuloma formation. There are no unique
markers for KCs that enable their distinction from newly recruited
monocyte or macrophage populations, so we developed a sys-
tem to track a small percentage of these cells during the course
of BCG infection based on their relatively slow rate of turnover in
bone-marrow radiation chimeras (Kennedy and Abkowitz, 1997).
LysM-EGFP mice were lethally irradiated and reconstituted with
wild-type nonfluorescent bone marrow. Four weeks after recon-
stitution, we were unable to detect any EGFP-expressing cells
(neutrophils and monocytes) in the blood of these chimeric ani-
mals, demonstrating complete engraftment by nonfluorescent
donor-derived bone marrow (Figure 2A). In contrast, EGFP-
expressing KCs were still readily detected in these chimeric
mice (Figure 2A) and represented approximately 20%of the total
F4/80+ cell population in the liver (data not shown). Thus, this
system permitted us to follow the fate of a defined population
of EGFP-expressing KCs during granuloma formation, because
any newly recruited blood-derived monocyte or macrophage
population would be nonfluorescent.
With the LysM-EGFP chimeric animals, we first examined
whether BCG infection increased the rate of KC turnover, asmight
be expected based on evidence for elevated amounts of macro-
phage apoptosis after BCG infection (Klingler et al., 1997; Matsu-
naga and Ito, 2000). LysM-EGFP chimeras were infected with
BCG,and3weeks later, a timewhen largenumbers of granulomas
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(A) MHC II-EGFP (top) or LysM-EGFP (bottom) animals were subject to intravital hepatic imaging, capturing a single 2-dimensional image every 1 s. One minute
after beginning image capture, 13 107 BCG-RFP bacteria were injected through an intravenous catheter. Data show intravital snapshots of the association be-
tween mycobacteria (red) and EGFP-expressing Kupffer cells (green) lining sinusoidal vessels that were demarcated by an intravenous injection of QD705 (blue).
Scale bar represents 25 mm. See also Movies S1 and S2.
(B) Enlarged regions from the last time points of the image series in (A). Scale bar represents 10 mm.
(C) Volumetric surface rendering from an intravital 3D image stack of a field of Kupffer cells (green) in a LysM-EGFP mouse 15 min after infection with BCG-RFP
bacteria (red). The animal had been injected with QD705 (blue) prior to imaging. The transparency of the Kupffer cell rendering was set to 50% to allow visual-
ization of the intracellular BCG (arrows). Bottom panel represents maximum intensity projection images across X, Y, and Z dimensions magnified from the boxed
region in the top panel. Scale bar represents 10 mm. See also Movie S3.are present in the liver, the number of EGFP-expressing KCs was
determined by flow cytometry. As shown in Figure 2, EGFP-ex-
pressingcellswerestill readily detectable in the liver of infectedan-
imals, although they represented a smaller percentage of the cells
than in uninfected mice. However, because the total number of
macrophages in the liver increasedby15-fold asa result of infec-
tion (Figure 2B), the absolute number of KCs in the liver remained
constant between uninfected and infected animals (Figure 2C).These data suggest that infection with BCG does not result in
the death of the infected KC population followed by replacement
with donor-derived, nonfluorescent macrophages. However, an
alternative explanation is that BCG infection induces proliferation
of the KC population that precisely compensates for a substantial
degree of BCG-induced KC death. To distinguish between these
possibilities,weusedBrdU incorporation todeterminewhether in-
fectionwithBCG inducedproliferationof theEGFP-expressingKC
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theproliferationofEGFP-expressingKCsbetweencontrol animals
and infected animals during the first 2 weeks of granuloma devel-
opment (Figure S3). Thus, BCG infection does not change the in-
trinsic turnover rate of the EGFP-expressing KCpopulation. Given
these findings, we conclude that the fluorescent cells in the liver at
3 weeks p.i. represent the same population that was present prior
to infection.
Figure 2. Kupffer Cells Persist and Spatially Redistribute during Mycobacterial Granuloma Formation
(A–C) EGFP-expressing cell populations in the blood and liver of infected (3 weeks p.i.) and uninfected LysM-EGFP bone-marrow chimeras were analyzed by flow
cytometry (A), and the absolute number of F4/80+ (B) and F4/80+ EGFP+ (C) cells in the liver was quantified (3 mice/group, mean ± SEM). Data are representative
of at least 3 independent experiments.
(D) Representative images of liver sections from LysM-EGFP bone-marrow chimeras (green) harvested at the indicated time points after infection with BCG-RFP
bacteria (red) and stained for themacrophagemarker F4/80 (blue). Right panels present amagnified view from the boxed region in left panels. Left panel scale bar
represents 50 mm; right panel scale bar represents 20 mm. Arrows indicate EGFP+ cells that contain BCG.
(E) Quantification of EGFP+ cell redistribution into granulomas over time obtained from images of liver sections. The graph represents the number of EGFP+ cells
associated with granulomas divided by the total number of EGFP+ cells for 842 cells analyzed at 2 weeks and 537 cells analyzed at 3 weeks (mean ± SEM of 5
mice per time point compiled from 3 independent experiments).
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the process of granuloma formation. Livers from infected and un-
infected chimeric animals were harvested at weekly intervals
during the first 3 weeks after infection and analyzed bymulticolor
high-resolution confocal imaging to look for changes in the spa-
tial distribution of KCs. Consistent with previous reports, distinct
hepatic granulomas were not observed until 2 weeks p.i. (Pellet-
ier et al., 1982). Between 2 and 3 weeks, we observed a gradual
redistribution of EGFP-expressing KCs into granulomas and
a corresponding reduction in the number of these cells in the sur-
rounding tissue (Figures 2D and 2E). These cells also underwent
dramatic morphological changes over the course of infection,
appearing in the mature lesion as large cells with numerous
membrane extensions (Movie S5). The granulomas appeared
to be composed of both uninfected and infected EGFP-express-
ing KCs, suggesting that resident macrophages present in the
liver are recruited into the granuloma structures irrespective of
infection status. Interestingly, the overall density of F4/80+ cells
in the surrounding sinusoids did not decrease, suggesting that
KCs that have migrated into granulomas can be replaced
through recruitment of monocytes from the blood. These
blood-derived monocytes also contribute to the cellularity of
the granuloma itself, because the total number of F4/80+ cells
Figure 3. Preferential Loss of Uninfected
Macrophage Populations after TNF-a
Blockade
(A) Representative images of liver sections from
LysM-EGFP bone-marrow chimeras (green) that
had been infected with BCG-RFP bacteria (white)
for 3 weeks before being treated with anti-TNF-
a or control IgG every other day for 4 days. Sec-
tions were stained with anti-F4/80 (red).
(B) Quantification of liver section images showing
the absolute number of EGFP+ cells and infected
EGFP+ cells remaining after anti-TNF-a or control
IgG treatment. Graph shows the mean ± SEM of
365 cells for the anti-TNF-a group and 546 cells
for the control IgG group compiled from a total of
5 mice obtained from 3 independent experiments.
(C)Thepercentageof infectedcellswasobtainedby
dividing the number of infected EGFP+ cells by the
total number of EGFP+ cells from (B) (mean ± SEM).
in the liver markedly exceeds the number
present in an uninfected animal and there
is no large excess of such cells in the
nongranulomatous hepatic parenchyma
at late time points (>2 weeks p.i.).
Infected Kupffer Cells Are
Preferentially Retained during
Granuloma Dissolution
As noted above, TNF-a plays a central
role in promoting granuloma formation
as well as in maintaining the cellularity
and protective function of established
granulomas (Kindler et al., 1989). Having
shown that liver granuloma formation
involves recruitment of tissue-resident
and blood-derived myeloid cells to foci of initially infected KCs,
we next examined the effects of anti-TNF-a on the cellular
composition of these granulomas. Time-course experiments re-
vealed that 2 to 4 days after anti-TNF-a treatment of animals
bearing established granulomas, there was a profound decrease
in both the number of macrophages and the size of granulomas
(Figure S4). At these early time points, anti-TNF-a had no effect
on mycobacterial burden in the liver but did increase bacterial
counts 2 weeks after the start of treatment (data not shown).
This delayed effect in altering mycobacterial burden may stem
from the relatively slow growth rate characteristic of BCG.
Based on these findings, livers of LysM-EGFP chimeras bearing
established granulomas were examined 4 days after the start of
anti-TNF-a treatment, by immunofluorescence histology. Consis-
tent with our earlier findings, the size of liver granulomas was dra-
matically reduced in anti-TNF-a-treatedmiceascompared tocon-
trol-treated animals (Figure 3A). However, despite this reduction in
cellularity, many granulomas in the anti-TNF-a-treated animals
continued to contain EGFP-expressing KCs (Figures 3A and 3B).
Although there was a substantial reduction in the total number of
EGFP-expressing cells in the liver after anti-TNF-a treatment in
comparison to control-treated animals, the number of BCG-
infected EGFP-expressing cells was comparable between the
Immunity 28, 271–284, February 2008 ª2008 Elsevier Inc. 275
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a higher percentage of the remaining EGFP-expressing cell popu-
lation was infected with BCG (Figure 3C). These data indicate that
the initial stages of anti-TNF-a-mediated granuloma dissolution in-
volve thepreferential lossofuninfectedmacrophages (whether de-
rived from blood monocytes or recruited uninfected KCs) and the
retentionofKCs thatcapturedmycobacteriaat thestart of infection
and nucleated granuloma formation prior to anti-TNF-a treatment.
Limited Macrophage and Mycobacterial Dynamics
during Granuloma Development
The preceding experiments examining the recruitment and redis-
tribution of monocytes and macrophages during granuloma de-
velopment and the loss of these populations during granuloma
dissolution suggest a certain degree of macrophage mobility.
However, whether these myeloid populations possessed the dy-
namic behavior and rapidmotility characteristic of many hemato-
poietic cell populations in secondary lymphoid organs remained
an open question. To examine macrophage and mycobacterial
dynamics during granuloma development, LysM-EGFP mice
were examined by hepatic 2P-IVM at various time points after
infection with BCG-RFP. At no time after infection were we able
to observe amarkeddegree of either uninfected or infected tissue
macrophage migration or a consistent pattern of influx by blood-
derived monocytes (Figure 4; Movies S6–S9). In general, the
immature granulomas present 2 weeks p.i. were composed of
loosely associated LysM-EGFP-expressingcells that dynamically
extended and retracted membrane processes (Figure 4B; Movie
S7),whereas themoremature structures at 3weeksp.i. contained
a dense network ofmacrophages that showed littlemobility com-
pared with the actively migrating neutrophils and monocytes in
the surrounding tissue (Figure 4C;Movies S8 andS9). To examine
cell motility within the mature granuloma in greater detail, at-
tempts were made to monitor migration of individual cells within
these structures. However, because of the high density of amor-
phously shaped, EGFP-expressing cells within a given granu-
loma, individual cell tracking was not possible. Instead, an image
subtraction-based analysis was used to detect movement of la-
beled structures within the granuloma, which resulted in the pref-
erential removal of signal derived fromstatic, but not frommoving
objects (Figure S7). With this method, dynamic populations of
EGFP-expressing neutrophils and monocytes were easily visual-
ized in the sinusoidal spacessurroundingeachgranuloma,but the
majority of fluorescence signal derived from macrophages pres-
ent in the core of the granuloma was lost, indicating a lack of mo-
tility over these time scales (Figure 4D; Movie S10). Consistent
with the lack of macrophage movement within lesions, individual
mycobacteria in the liver also appeared relatively immobile
throughout granuloma development (Movies S6–S8). We thus
conclude that the macrophage aggregation process initiated by
mycobacterial infection occurs over long time periods that are
not readily visualizedby the techniquespresented in thesestudies
and that once incorporated into the granuloma structure, myeloid
cells show little net cellular displacement.
T Cells Display Rapid Motility but Restricted Migration
inside Granulomas
The granuloma microenvironment is thought to foster interac-
tions between innate and adaptive immune system components
276 Immunity 28, 271–284, February 2008 ª2008 Elsevier Inc.that are critical for its protective function. Therefore, we sought
to understand how T cells behave within the context of the rela-
tively staticmyeloid structure that was observed in the preceding
experiments. To facilitate imaging and tracking of individual T
cells, we reconstituted RAG-1-deficient mice with a mixture of
polyclonal EGFP-expressing CD4+ T cells and nonfluorescent
CD4+ T cells, CD8+ T cells, and B cells, thus allowing visualiza-
tion of a fraction (30%–60%) of the CD4+ T cell population. An-
imals were allowed to reconstitute fully over a period of at least 4
weeks and were subsequently infected with BCG-RFP. RAG-
deficient animals are normally unable to control BCG infection,
but reconstitution of the ab T cell compartment of these animals
in this manner enables them to mount a protective immune
response characterized by bacterial clearance (Feng andBritton,
2000; Kaufmann et al., 1995; Ladel et al., 1995b).
Three weeks after BCG-RFP infection, animals were analyzed
by 2P-IVM. The location and extent of individual granulomas
could be easily identified by the disruption created in the regular
sinusoidal pattern, visualized with an injected fluorescent blood
tracer (Figure 5A, left). This observation is consistent with immu-
nofluorescence histology performed on liver sections from in-
fected LysM-EGFPmice, which revealed that sinusoids abruptly
terminate at the border of granulomas (Figure S5B). Large
numbers of EGFP-expressing T cells were seen within both the
confines of individual granulomas as well as within the surround-
ing sinusoidal vessels (Figure 5A). Comparing the migratory
dynamics of the intra- and extralesional T cells revealed that
those within granulomas display only a slightly lower velocity
but a dramatically reduced spatial displacement over time
when compared with cells within the sinusoids (Figures 5B and
5D; Movie S11). The finding that the displacement of T cells in-
side of granulomas reached a plateaumuch sooner than sinusoi-
dal T cells is consistent with their significantly lower confinement
ratio (Figure 5C), indicating constrained migration.
TNF-a blockade had only marginal effects on T cell behavior in
the granuloma. Although 4 days after the start of anti-TNF-
a treatment, granuloma-associated T cells in RAG-reconstituted
animals did display a decrease in their overall displacement over
time when compared to control-treated animals (Figures S6A
and S6B), this likely resulted from the dramatic reduction in gran-
uloma size. We also observed a small but significant decrease in
T cell velocities after anti-TNF-a treatment (Figure S6C); how-
ever, whether this difference results from changes in the chemo-
kine, cytokine, or adhesive environment that the T cells encoun-
ter or simply an increase in the density of the granuloma through
which the T cell must travel is unresolved at present.
Visualizing the migration of EGFP-expressing T cells relative to
themycobacterial populationswithinmature granulomas revealed
the swarming behavior of T cells around a central core ofmyeloid-
cell resident BCG (Figure 5E;Movie S12), with an occasional T cell
divisionevent (MovieS13).Overall, thesedata reveal thatTcells in-
side of granulomas are highlymotile but display a restrictedmigra-
tion pattern, tending to remain localized within the borders of the
granuloma rather than rapidly exiting and re-entering the structure.
Exogenous Effector T Cells Are Rapidly Recruited
into and Retained within Granulomas
Imaging of T cell dynamics in granulomas revealed only an occa-
sional cell entering or exiting the lesion (Figure 5F). Quantifying
Immunity
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(A–C) LysM-EGFP mice (green) that had been infected with BCG-RFP bacteria (red) for 1 (A), 2 (B), or 3 (C) weeks were subject to hepatic IVM. Individual time
points from 4D image series are shown. Arrows in (A) and (B) point to extragranuloma macrophages associated with mycobacteria. See also Movies S6–S9.
(D) 4D image series of a granuloma from a LysM-EGFP mouse (green) at 3 weeks p.i. with BCG-RFP. The top panel shows the raw images whereas the bottom
panel shows the same data after subtracting fluorescence intensity at each time point by amean intensity time projection image obtained from the same data set,
thus preferentially removing objects with minimal spatial displacement. See also Movie S10.granuloma-associated T cell turnover by 2P-IVM of BCG-in-
fected RAG-1-deficient animals that had been reconstituted
with a mixture of polyclonal EGFP-expressing CD4+ T cells and
nonfluorescent CD8+ T cells and B cells (100% of CD4+ T cells
expressing EGFP) revealed that on average T cells enter into
and exit from a granuloma at a rate of 5.7 ± 2.1 and 5.6 ± 1.6
(mean ± SD) cells per hour, respectively. Because of their ex-
tremely high density and rapid rate of motility, it was difficult toobtain accurate counts of granuloma-associated T cells in these
animals; however, rough estimates suggest that these entry and
exit rates correspond to less than 7% of the total T cell popula-
tion being replaced per hour.
These relatively low rates of T cell entry and egress from the
granuloma could indicate that a mature lesion represents a rela-
tively closed structure, with physical and/or chemical barriers
that restrict free movement of lymphoid cells into and out ofImmunity 28, 271–284, February 2008 ª2008 Elsevier Inc. 277
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Visualizing Mycobacterial Granulomatous ResponsesFigure 5. Rapid but Restricted Migration of Granuloma-Associated T Cells
(A) RAG1-deficient animals reconstituted with EGFP-expressing and nonexpressing CD4+ T cells (30% of CD4+ T cells expressing EGFP in reconstituted an-
imal) were infected with BCG-RFP bacteria for 3 weeks prior to performing hepatic IVM. Animals were injected with BSA-TR (white) immediately before imaging to
visualize the sinusoidal network. A representative image from a 4D data set showing the disruption in the sinusoidal network caused by the granuloma lesion (left),
the location of T cells within these structures (middle), and the migration paths of T cell inside (red) and outside (blue) the granuloma (right). See also Movie S11.
(B–D) Quantification of velocity (B), confinement ratio (total displacement/cumulative path length) (C), and displacement over time (D) for T cells located inside
(red) and outside (blue) of granulomas. For (B) and (C), data points represent individual cells compiled from 4 individual experiments. Graphs showmean ± SEM.
The p values from a Mann-Whitney test are shown.
(E) Granuloma-associated EGFP-expressing T cells (green) in a reconstitutedRAG animal (60%of CD4+ T cells expressing EGFP in reconstituted animal) can be
seen swarming around a core of mycobacteria (white). Right panel shows migration paths of individual T cells within the granuloma. See also Movie S12.
(F) Enlarged region of the granuloma from (A) showing T cells entering (red track), exiting (blue track), and turning at the border (purple track) of a granuloma.the lesion. Alternatively, among the T cells traversing the liver,
only a small fraction may posses the molecular profile (chemo-
kine receptors, integrins, selectins, etc.) needed for granuloma
entry, and once inside the granuloma, these cells could be
retained in the structure based on adhesive or chemotactic
mechanisms. To differentiate between these possibilities, we
developed a system to examine the permeability of granulomas
based on their ability to recruit exogenous effector T cells
acutely.
2P-IVM was performed on the livers of granuloma-bearing
mice that had been infected 3 weeks earlier with BCG-RFP. Dur-
ing the imaging session, preactivated, CMTPX-labeled OT-II
278 Immunity 28, 271–284, February 2008 ª2008 Elsevier Inc.TCR transgenic T cells on a RAG1-deficient background (OTII-
RAG) were adoptively transferred into the recipient animal
through an i.v. catheter. Because T cells can localize to granulo-
mas in the absence of antigen recognition (Co et al., 2006), we
hypothesized that these OTII-RAG cells would serve as a source
of T cells with the potential to enter the granuloma. By using
a fluorescent blood tracer to delineate the borders of individual
granulomas, we observed a rapid recruitment of activated T cells
into these structures beginning 20 min after T cell transfer, with
increasing numbers of cells accumulating within the granuloma
over the next 2 hr (Figures 6A and 6B; Movie S14). The relative
ease with which T cells entered the granuloma is consistent
Immunity
Visualizing Mycobacterial Granulomatous ResponsesFigure 6. T Cells Are Rapidly Recruited to and Retained within Granuloma Structures
(A) Mice that had been infected with BCG-RFP bacteria 3 weeks earlier were injected with BSA-647 (white) to visualize the sinusoidal network and subjected to
hepatic IVM. 15min after the start of the imaging session, CMTPX-labeled in vitro stimulated OT-II T cells (red) were injected i.v. through a catheter to look at T cell
entry into the granulomas. See also Movie S14.
(B) Quantification of T cell recruitment over time into 10 granulomas (black lines indicate individual granulomas; red line indicates mean values). Data were com-
piled from 3 individual experiments.
(C) CMTPX-labeled in vitro stimulated OT-II T cells (red) were transferred into mice that had been infected with BCG-RFP bacteria 3 weeks earlier. 12 hr later, the
animals were injected with BSA-647 (white) to visualize the sinusoidal network and the migration of T cells within individual granulomas was visualized with
hepatic IVM. Tracks of individual granuloma-associated T cells are shown (red). See also Movie S15.
(D) Mice that had been infected with BCG-RFP bacteria for 3 weeks were treated with control IgG or anti-TNF-a for 4 days and subsequently subjected to hepatic
IVM. 5min after the start of imaging, CMTPX-labeled in vitro stimulated OT-II T cells (red) were injected i.v. through a catheter to examine acute T cell entry into the
granulomas. Images represent a single time point from a 4D image series captured after 3 hr of continuous imaging.
(E) Quantification of both the average rate of T cell recruitment into granulomas over time (top) and the average rate of recruitment adjusted for granuloma size
(bottom) (mean ± SEM from 45 control IgG-treated and 39 anti-TNF-a-treated granulomas compiled from 2 independent experiments).with immunofluorescence staining of fixed liver sections for col-
lagen IV, which failed to reveal a defined extracellular matrix bar-
rier on the periphery of the granuloma that might block entry into
these structures. Rather, much of the collagen structure within
the granuloma appeared to come from the remnants of sinusoi-
dal vessels that had been invaded by macrophages during gran-
uloma development (Figure S5A).
The extent of T cell recruitment varied widely between individ-
ual granulomas (Figure 6B), suggesting heterogeneity in either
the vascular delivery of T cells to a granuloma or in the ability
of an individual granuloma to attract T cells. In either case, exam-
ining animals that had been given dye-labeled T cells 12–16 hr
prior to imaging revealed that many granulomas contained largenumbers of T cells exhibiting active but spatially restrictedmigra-
tion (Figure 6C; Movie S15). These data demonstrate that over
relatively short periods of time, effector T cells can freely enter,
but not exit, the mature granuloma.
We also examined the effect of blocking TNF-a-derived sig-
nals on the efficiency of effector T cell recruitment into granulo-
mas. Animals bearing established granulomas were treated with
anti-TNF-a or control IgG for 4 days and subsequently trans-
ferred with in vitro stimulated, dye-labeled effector T cells. Mon-
itoring of the acute recruitment of T cells into granulomas was
performed with 2P-IVM (Figure 6D). Quantification of this recruit-
ment revealed an impaired ability of granulomas to efficiently
recruit T cells after TNF-a blockade, which was only partially
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animals (Figure 6E). These data suggest that the activation status
of granulomas is a critical factor in their ability to attract effector
T cells.
RestrictedMigration ofGranuloma-Associated TCells Is
Defined by a Macrophage-Delineated Border
The preceding experiments revealed the disparate dynamic be-
havior between granuloma-associated macrophages and T
cells, with the former being largely sessile and the latter actively
migratory. In lymph nodes, we have reported that rapidly migrat-
ing lymphocytes preferentially move along fixed stromal cell net-
works (Bajenoff et al., 2006), which likely involves the chemoki-
netic stimulation of the T cells through stromal cell-associated
chemokines such as CCL21 (Asperti-Boursin et al., 2007; Okada
and Cyster, 2007;Worbs et al., 2007). Given these prior observa-
tions and the possible parallel of these lymph node findings to
the results reported here for lymphocyte versus macrophage
elements in granulomas, we focused on the physical relationship
between these two populations. In vitro stimulated, dye-labeled
OTII-RAG T cells were transferred into LysM-EGFPmice bearing
established granulomas, and fixed liver sections from these an-
imals were examined by immunofluorescence static imaging.
We observed both endogenous and exogenous CD4+ T cell pop-
ulations tightly packed betweenmacrophage cell junctions in the
granuloma interior (Figure 7A). To characterize the dynamics of
these transferred T cells relative to the dense macrophage net-
work, dye-labeled effector T cells were again transferred into
granuloma-bearing LysM-EGFP mice and 2P-IVM was per-
formed 12–16 hr later. These data revealed that as a T cell mi-
grates through a granuloma, it actively displaces macrophage
membrane processes so it can pass through these very closely
juxtaposed cells (Movie S16). Strikingly, granuloma-associated
T cell migration also appeared to be strictly limited by the mye-
loid cell-defined border (Figures 7B and 7C; Movie S17). In
some granulomas, macrophages could be seen extending out
from the periphery of the structure. In these cases, T cells were
often observed migrating along these cellular projections (Fig-
ure 7D; Movies S18 and S19). Interestingly, in vitro generated ef-
fector T cells that were transferred into LysM-EGFP animals
bearing immature granulomas (12 days p.i.) were also recruited
to these nascent structures and actively migrated in close appo-
sition to the macrophage aggregates (Movie S20). Taken to-
gether, these data suggest that direct interactions between T
cells and macrophages may play a critical role in defining the
limits of T cell migration once these lymphocytes have entered
the granuloma and raise the intriguing possibility that T cell
movement is actively promoted by signals physically associated
with this underlying myeloid network.
DISCUSSION
The development of a mycobacterial granuloma involves the
spatial (re)organization of diverse cell types within the infected
tissue, culminating in the generation of an inflammatory lesion
that is the primary effector site for the host antipathogen re-
sponse. The structural architecture of the granuloma is presum-
ably critical for its protective function, both by creating physical
barriers to prevent bacterial dissemination as well as by facilitat-
280 Immunity 28, 271–284, February 2008 ª2008 Elsevier Inc.ing interactions between key cell types such as antigen-specific
T cells and macrophages. Although static histological observa-
tions and studies of gene-targeted mice have provided substan-
tial insight into the mechanisms involved in granuloma formation
and host defense, fundamental questions remain regarding the
behavior of individual cell types at various stages of the myco-
bacterial response and the corresponding impact of these be-
haviors on granuloma function.
The data presented here reveal the mycobacterial granuloma
to be a highly dynamic structure containing cell typeswith unique
migrational behaviors. Within the liver, the primary target organ
after systemic mycobacterial infection, clearance of the patho-
gen is mediated through direct capture and phagocytosis of
blood-borne bacteria by KCs. Both infected and uninfected
KCs appear to persist throughout the subsequent process of
granuloma development, with the uninfected KCs gradually re-
distributing from the surrounding tissue into individual granulo-
mas that contain the initially infected, surviving KCs. These two
KC populations and additional myeloid cells derived from the
blood all undergo dramatic morphological changes over time,
from round or stellate cells to large, tightly packed epithelioid
forms that presumably correspond to the large giant cells seen
in standard histological preparations. Given the long-term per-
sistence of the initially infected macrophage population, their
central location in the mature structure, and the selective persis-
tence of these infected KCs during granuloma dissolution in the
presence of anti-TNF-a, it appears that these infected cells nu-
cleate granuloma formation, perhaps by serving as an early
source of chemoattractant that facilitates initial macrophage ag-
glomeration (Flynn and Chan, 2001; Peters and Ernst, 2003).
These data also suggest that uninfected macrophages have
a unique requirement for TNF-a-derived signals for survival
and/or retention within the granuloma structure that is not shared
by infected macrophages. Overall, these data demonstrate that
the mycobacterial granuloma is comprised of a diverse set of re-
cruited monocytes/macrophages and infected and uninfected
tissue resident macrophages, each of which may play a unique
role in mycobacterial containment.
Examination of the macrophage population in mature granulo-
mas by intravital microscopy revealed dynamic motion of mem-
brane processes, but little net cellular displacement. These data
are consistent with a previous study that examined the dynamics
of macrophages after infection of zebrafish embryos with M.
marinum (Davis et al., 2002). However, in contrast to our obser-
vations, this earlier report also demonstrated significant macro-
phage migration outside of granulomas at various stages of the
granulomatous response. Indeed, with an M. marinum superin-
fection model in adult frogs and zebrafish, a more recent report
by this same group demonstrated that newly infected macro-
phages can home to established granulomas as early as 3 days
after reinfection (Cosma et al., 2004). Although our histological
studies with the LysM-EGFP chimeric animals clearly suggest
migration of motile macrophage populations into granulomas,
the time frame of this process (>1 week) may be too slow to de-
tect by intravital imaging techniques limited to data collection
of <3 hr. Indeed, macrophage aggregation begins in zebrafish
embryos within 3 days p.i., suggesting that the entire process
of macrophage accretion may be greatly accelerated in this spe-
cies. Alternatively, intrinsic differences in the pathogenicity of the
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(A) CMTPX-labeled in vitro stimulated OT-II T cells (red) were transferred into LysM-EGFP mice (green) that had been infected with BCG-RFP bacteria 3 weeks
earlier. 12 hr later, livers were fixed, sectioned, and stained with an antibody to CD4 (white) and a nuclear dye (blue). Scale bar represents 15 mm.
(B) CMTPX-labeled in vitro stimulated OT-II T cells (red) were transferred into LysM-EGFP mice (green) that had been infected with BCG-RFP bacteria 3 weeks
earlier. 12 hr later, BSA-647 (white) was injected into the animals to visualize the sinusoidal network and hepatic IVMwas performed. A single time point from a 4D
data set showing T cells in relation to sinusoidal network (left), T cells in relation to macrophages (middle), and T cell migration paths (blue) in relation to macro-
phages (right). See also Movie S17.
(C) XY (top) and XZ (bottom) projection images from the upper right quadrant of the granuloma from (A) showing T cell paths (blue) in relation to macrophages
(green).
(D) Intravital snapshots of a T cell migrating along macrophage processes that extend from the granuloma. See also Movies S18 and S19.
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was analyzed, and/or the specific monocyte or macrophage
populations recruited during infection may account for these dif-
ferences. Interestingly, a recent report has demonstrated rapid
migration of murine microglial populations in response to brain
injury (Davalos et al., 2005), suggesting that the degree of mac-
rophage motility in mammals may be at least partially tissue and/
or stimulus dependent.
The limited dynamics exhibited by macrophages during the
mycobacterial response was in direct contrast to the rapid motil-
ity characteristic of granuloma-associated T cells. A particularly
striking observation was that despite this dynamic behavior,
these T cells were still efficiently retained in the granuloma.
What mechanisms might function to restrict the ability of T cells
to leave the lesion? One possibility is a physical barrier at the
surface of the structure. Findings from several studies have re-
vealed that recently activated antigen-nonspecific T cells can
enter established granulomas (Co et al., 2006; Hogan et al.,
2007; Sewell et al., 2003), but given that in these previous studies
T cells had the opportunity to enter the lesion over a relatively
long time period (1 or more weeks), the permeability of the gran-
uloma border was unclear. We found that T cells can enter gran-
ulomas within minutes of localizing to their borders and subse-
quently accumulate within these structures, displaying rapid
motility, highly restricted migration, and limited egress into the
surrounding sinusoidal space. Although our data do not rule
out the existence of a passive physical barrier that would act
as a one-way valve, allowing T cells to freely enter the granuloma
but retarding their subsequent egress, we feel that this is unlikely
and favor the hypothesis that retention of migrating T cells within
the granuloma results from interactions between T cells and the
granuloma macrophage network. This same macrophage net-
work may also be important for sustaining T cell motility within
the granuloma. These ideas are consistent with our data showing
that the extent of T cell migration within the granuloma appears
to be restricted to amacrophage-delineated border and that gra-
nuloma-associated migrating T cells must constantly squeeze
through narrow cell junctions created by a dense macrophage
network. Upon entering the granuloma, T cells could become at-
tached to themacrophage network through specific adhesive in-
teractions between proteins expressed on the two cell types (van
den Berg et al., 1992) and/or immobilized chemokines that are
recognized by T cells and presented on the surface of macro-
phages, perhaps through interactions with plasma membrane-
bound gylcosaminoglycans (Slimani et al., 2003). Interestingly,
production of T cell-specific chemokines by macrophages is
thought to be dependent on TNF-a-derived signals (Algood
et al., 2003), which may explain our data showing that granulo-
mas in animals treated with anti-TNF-a for short periods of
time are less efficient at recruiting T cell from the surrounding
tissue. Our observations that granuloma-associated T cells mi-
grate in close apposition to and within the confines of a macro-
phage scaffold are reminiscent of our recent findings that naive
T cells specifically migrate along a stromal cell network that
defines the paracortical region of the lymph node (Bajenoff et al.,
2006). Thus, an intriguing possibility is that T cells in different
activation states and in different tissuemicroenvironments utilize
related mechanisms for both locomotion and to define spatial
territories.
282 Immunity 28, 271–284, February 2008 ª2008 Elsevier Inc.The data presented here provide insight into how dynamic cel-
lular processes in both innate and adaptive immune system
components contribute to processes of granuloma formation,
maintenance, and dissolution. In particular, our findings empha-
size that a protective granuloma environment involves the TNF-
a-dependent maintenance of a static myeloid cell scaffold that
supports the migration of a highly motile population of effector
T cells. The use of intravital imaging techniques such as those
employed here, coupled with genetic or chemical disruption of
key candidate signaling molecules involved in cell migration
and effector activity, should provide a greater understanding of
the specific pathways utilized to regulate cell behavior within
the granuloma and thereby help to reveal fundamental mecha-
nisms of mycobacterial control.
EXPERIMENTAL PROCEDURES
Mice and Animal Procedures
C57BL/6 LysM-EGFP knockin mice (Faust et al., 2000) were a gift from S. Graf
(Albert Einstein University, NY). C57BL/6 IAb-EGFP knockin mice (Boes et al.,
2002) were a gift from H. Ploegh (Harvard University, MA). C57BL/6 mice and
transgenic mice expressing EGFP under the control of the human ubiquitin
promoter (UbEGFP) (Schaefer et al., 2001) were obtained from Jackson Lab-
oratories. C57BL/6 RAG1-deficient (Mombaerts et al., 1992) and C57BL/6
CD45.2 congenic mice were obtained from Taconic Laboratories through
a special contract with the NIAID. OT-II TCR transgenic (Barnden et al.,
1998) RAG1-deficient mice were obtained from Taconic Laboratories through
the NIAID exchange program.
For the generation of bone-marrow chimeras, C57BL/6 LysM-EGFP mice
were g-irradiated with two doses of 500 rads from a cesium source and sub-
sequently reconstituted with 23 106 C57BL/6 CD45.2 congenic bone-marrow
cells. For anti-TNF-a-induced granuloma dissolution, BCG-infected animals
were injected i.p. with 1 mg of anti-TNF-a (XT22.11) or control anti-b-galacto-
sidase antibody (GL113) every other day until the time of analysis. For RAG re-
constitutions, CD4+ T cells were purified from the LNs of UbEGFP mice with
a MACs negative selection kit (Miltenyi Biotech). Biotinylated anti-NK1.1
(PK136) (BD Biosciences) was added to the negative depletion cocktail to
remove NK and NKT cells. EGFP-expressing CD4+ T cells were mixed with un-
purified B6 lymphocytes and injected i.v. into RAG1-deficient recipient animals
to obtain animals with a fraction of fluorescent CD4+ T cells. Animals were
allowed to reconstitute for a minimum of 4 weeks prior to infecting with
BCG. All animal procedures used in this study were approved by the Animal
Care and Use Committee, NIAID, NIH.
Bacterial Cultures, Infections, and Quantification
M. bovis BCG strain Pasteur expressing the red fluorescent protein dsRed
(BCG-RFP) has been previously described (Abadie et al., 2005). BCG-RFP
or nonrecombinant M. bovis BCG strain Pasteur were expanded to log phase
in Middlebrook 7H9 liquid medium supplemented with ADC (Difco), washed,
aliquoted in PBS, and stored at 80C until further use. BCG-RFP bacteria
were grown in the presence of Hygromycin (Sigma). Quantification of bacterial
stocks for infection and bacterial loads in organs was performed by culture on
7H11 agar supplemented with OADC (Difco). For mycobacterial infections,
animals were inoculated i.v. with 2 3 106 BCG, unless otherwise specified.
In Vitro T Cell Stimulation and Adoptive Transfers
OTII-RAG-deficient TCR transgenic LN cells were stimulated with 2 mM oval-
bumin 323-339 peptide plus mitomycin C-treated, T cell-depleted C57BL/6
splenocytes. Two days after stimulation, cells were expanded in the presence
of 30 U/ml recombinant human IL-2 (R&D systems) and used for experiments 7
days after activation. In vitro generated effector T cells were labeled with 2 mM
CMTPX or 2 mM TAMRA-SE (Invitrogen) as described (Qi et al., 2006). 13 107
cells were injected i.v. into animals bearing established granulomas either
before or during imaging, as indicated.
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Livers were fixed by portal vein perfusion with 4% paraformaldehyde/PBS,
excised from the animals, and fixed for an additional 12 hr followed by dehy-
dration in 30% sucrose/PBS prior to embedding in OCT freezing media. 16
mm sections were cut on a CM3050s cryostat (Leica) and adhered to Super-
frost Plus slides (VWR). Sections were permeablized and blocked in PBS con-
taining 0.3% Triton X-100 (Sigma) and 10% goat serum (Jackson Immunore-
search) followed by staining with Alexa Fluor 647-conjugated anti-CD3
(clone 17A2), unconjugated anti-MHC class II (clone 2G9) (all from BD Biosci-
ences), Alexa Fluor 647-conjugated anti-F4/80 (clone BM8) (Caltag), rabbit
polyclonal anti-LYVE-1 (Novus Biologicals), and rabbit polyclonal anti-Colla-
gen IV (Abcam). Unconjugated primary antibodies were stained with Alexa
Fluor conjugated secondary antibodies (Invitrogen). Stained slides were
mounted with Prolong Gold or Prolong Gold plus DAPI (Invitrogen), and 3D
image stacks were acquired on a LSM 510 confocal microscope (Carl Zeiss
Microimaging). Images are displayed as 2D maximum intensity projections.
Two-Photon Intravital Hepatic Imaging and Image Analysis
Mice were anesthetized with isoflurane (Baxter) as previously described (Qi
et al., 2006), the abdomen of the animal was shaved, and a midline and sub-
costal incision was made through the dermis. A high-temperature cautery
was used to open the peritoneum. The falciform ligament was resected and
the liver gently exteriorized onto a glass coverslip attached to a custom-
made steel imaging platform. The liver was covered with plastic wrap, the in-
cision was packed with moist gauze, and the imaging platform was sealed to
prevent dehydration. In some experiments, a catheter was placed into the tail
vein with a 30GA needle attached to PE-10 tubing (Becton Dickinson) and
secured with Durapore Tape (Fischer Scientific). Liver sinusoids were visual-
ized by injecting Texas Red-conjugated bovine serum albumin (BSA-TR),
Alexa Fluor-647-conjugated BSA (BSA-647), or nontargeted Quantum Dots
705 (QD705) (Invitrogen) i.v. immediately prior to imaging. Approximate
molecular weights for BSA conjugates and QD705 are 66 kDa and 1500
kDa, respectively.
Images were acquired with an inverted LSM 510 NLO multiphoton micro-
scope (Carl Zeiss Microimaging) enclosed in a custom-built environmental
chamber that was maintained at 35C with heated air. This system had been
custom fitted with three external nondescanned PMTdetectors in the reflected
light path. Images were acquired with either a 203/0.8 NA air objective or
a 403/1.2 NA water immersion objective. Fluorescence excitation was pro-
vided by a Chamelon XR Ti:Sapphire laser (Coherent). EGFP and dsRed
were excited at 920 nm while CFSE and CMTPX were excited at 820 nm. Typ-
ical voxel dimensionswere 0.93 0.93 2–3 mmwith the 203 objective and 0.45
3 0.45 3 1–2 mm with the 403 objective. For 4-dimensional (4D) data sets, 3-
dimensional stacks were captured every 1min, unless otherwise specified. For
images displayed as volumetric perspective renderings, the dimensions of the
imaging frame in microns are shown in the figure.
Raw imaging data were processed with Imaris (Biplane) with a Gaussian
filter used for noise reduction. Automatic 3D object tracking with Imaris Spots
was aided with manual corrections to retrieve cell spatial coordinates over
time. These data were imported into MatLab (MathWorks) for calculating cell
velocities, displacements, and confinement ratios (total displacement/cumu-
lative path length). For calculating T cell recruitment into granulomas over
time, the number of T cell inside individual granulomas was counted at multiple
time points throughout 4D image series. Area-normalized data were obtained
by dividing the number of T cells inside a granuloma at a given time point by the
2D area of the granuloma in the XY dimension. For dynamic display of imaging
data sets, image sequences exported from Imaris were composed in AfterEf-
fects (Adobe) to produce video clips.
Intrahepatic Mononuclear Cell and Peripheral Blood Leukocyte
Isolation and Analysis
Kupffer cells were quantified by isolating intrahepatic mononuclear cell (IHMC)
as previously described (Berenzon et al., 2003), with slight modification. In
brief, livers were perfused through the portal vein with 0.5 mg/ml of Liberase
CI (Roche) and 0.05% DNase I (Bohreinger Manheim) in PBS containing cal-
cium and magnesium and subsequently excised, digested for an additional
45 min at 37C, and passed through a 100 mm cell strainer (Falcon). Cell sus-
pensions were washed, resuspended in a 33% Percoll solution (AmershamBiosciences), and centrifuged at 800 3 g for 20 min. Cells were analyzed by
flow cytometry. Peripheral blood was collected from mice through a cardiac
puncture into EDTA-containing tubes. Erythrocytes were lysed with ACK lysis
buffer (Biowhittaker), and cells were washed and analyzed by flow cytometry.
Blood- and liver-derived cell populations were stained with anti-GR1-PE (BD
Bioscience) and anti-F4/80-Alexa 647 (Caltag). Dead cells were gated out of
the analysis with a 7AAD (BD Bioscience) counterstain. Flow cytometric data
were collected on a FACSCalibur or an LSR II (BD Biosciences) and analyzed
with FlowJo software (TreeStar).
Supplemental Data
Seven figures and 20 movies are available at http://www.immunity.com/cgi/
content/full/28/2/271/DC1/.
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